Abstract

Research Article

Profile of vitamin D receptor polymorphism Bsm I and FokI in end stage renal disease Egyptian patients on maintenance hemodialysis

EL-Attar HA*, Mokhtar MM and Gaber EW

Published: 30 August, 2017 | Volume 1 - Issue 1 | Pages: 026-040

Objective: In end stage renal disease, the synthesis of vitamin D is disturbed.Hyperparathyroidism is one of the key factors in the pathogenesis of many of the complications of dialysis mainly bone and cardiovascular complications.Aim:This study aimed at assessing vitamin D receptor gene polymorphisms BsmIand FokI in Egyptian patients with end stage renal disease on maintenance haemodialysis and the assosciation of these polymorphisms with cardiovascular complications and hyperparathyroidism among these patients.

Methods: One hundred subjects, recruited from Medical Research Institute, from March to July 2014, divided into two main groups; the control group which included thirty apparently healthy subjects and the patients group which included seventy patients with end stage renal disease on maintenance haemodialysis with median 4 years. To all studied subjects, detailed history was taken, thorough physical examination, carotid intima media thickness, presence of plaques and ECG ischemic changes. Laboratory investigations included serum levels of: glucouse, urea, creatinine, uric acid, albumin, total cholesterol, low and high density lipoproteins, calcium, phosphorus, and CRP as well as plasma PTH level. For molecular studies, the detection of BsmI and FokI polymorphisms using polymerase chain reaction and restriction fragment length polymorphism (PCR / RFLP) technique.

Results: 1.No statistically significant difference could be detected in both BsmI and FokI gene polymorphisms between the hemodialysis patients and the controls, suggesting that the development of ESRD had no relation with either VDR BsmI or FokI gene polymorphisms.2.No statistically significant difference were found in these polymorphisms between the hemodialysis patients with or without cardiovascular complications or between patients with PTH level less or more than 300 pg/ml. These results suggest that the development of cardiovascular complications and secondary hyperparathyroidism among Egyptian patients on maintenance haemodialysis cannot be attributed to these two gene polymorphisms.

Conclusion: No association could be found between the variant alleles of BsmI and FokI gene polymorphisms and the development of ESRD, cardiovascular complications and secondary hyperparathyroidism among the studied samples of Egyptian patients on maintenance haemodialysis.

Read Full Article HTML DOI: 10.29328/journal.jcn.1001005 Cite this Article Read Full Article PDF

Keywords:

Chronic renal failure; End stage renal disease (ESRD); Hemodialysis; Gene polymorphism; Vitamin D receptor polymorphism; Vdr; Bsmi; Foki

References

  1. Tang J. Vitamin D and its role in chronic kidney disease. Nephrology Rounds. 2009; 7: 1-6.
  2. Feldman D, Pike JW, Adams JS. Vitamin D, 3rd Ed. Academic Press Elsevier, Amsterdam. 2011; 1245-90.
  3. Hollick MF. Vitamin D deficiency. N Engl J Med. 2007; 357: 266-2681. Ref.: https://goo.gl/6ioGRP
  4. Grzegorzewska AE, Świderska MK, Mostowska A, Warchoł W, Jagodziński PP. Polymorphisms of vitamin D receptorsignaling pathway genes and calcium-sensing receptor gene in respect to survival of hemodialysis patients: A prospective observational study. Int J Endocrinol. 2016; 2383216: 11. Ref.: https://goo.gl/Vm7YAc
  5. Kato S. The function of vitamin D receptor in vitamin D action. J Biochem. 2000; 127: 717-722. Ref.: https://goo.gl/2UKFNz
  6. Thorne J, Campbell MJ. The vitamin D receptor in cancer. Proc Nutr Soc. 2008; 67: 115-127. Ref.: https://goo.gl/PNpRJL
  7. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004; 80: 1678-1688. Ref.: https://goo.gl/MDQHxA
  8. Germain P, Staels B, Dacquet C, Spedding M, Laudet V. Overview of nomenclature of nuclear receptors. Pharmacol Rev. 2006; 58: 685-704. Ref.: https://goo.gl/jQsXra
  9. Genetics home reference. http://ghr.nlm.nih.gov/gene/VDR.
  10. Bouillon R, Carmeliet G, Verlinden L, Van Etten E, Verstuyf A, et al. Vitamin D and Human Health: Lessons from vitamin D receptornull mice. Endocr Rev. 2008; 29: 726-776. Ref.: https://goo.gl/mZMxYS
  11. Valdivielso JM, Fernandez E. Vitamin D receptor polymorphism and disease. Clin Chim Acta. 2006; 371: 1-12. Ref.: https://goo.gl/4Tvt1s
  12. Barreiro LB, Laval G, Quach H, Patin E, Quintana-Murci L. Natural selection has driven population differentiation in modern humans. Nat Genet. 2008; 40: 340-345. Ref.: https://goo.gl/6V16kH
  13. Bid HK, Mittal RD. Study of vitamin-D receptor (VDR) gene start codon polymorphism (Fok I) in healthy individuals from North India. Indian J Hum Genet. 2003; 9: 51-4.
  14. Li WH, Gu Z, Wang H, Nekrutenko A. Evolutionary analyses of the human genome. Nature 2001; 409: 847-849. Ref.: https://goo.gl/jE2BEY
  15. Uitterlinden AG, Fang Y, van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338: 143-156. Ref.: https://goo.gl/mtd2hs
  16. Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev. 2000; 22: 203-217. Ref.: https://goo.gl/nRPwNd
  17. http://www.snpedia.com/index.php/Rs1544410
  18. Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, et al. Functionally relevant polymorphisms in the human nuclear vitamin Dreceptor gene. Mol Cell Endocrinol. 2001; 177: 145-1459. Ref.: https://goo.gl/VdS6vT
  19. http://www.snpedia.com/index.php/Rs2228570
  20. Mosos I, Marginean O. Links between vitamin Ddeficiency and cardiovascular diseases. Biomed Res Int. 2015; 109275: 12. Ref.: https://goo.gl/9puMuk
  21. Nigwekar SU, Tamez H, Thadhani RI. Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD). Bonekey Rep. 2014; 3: 498. Ref.: https://goo.gl/853Fi
  22. Tomasello S. Secondary hyperparathyroidism and chronic kidney disease. Diabetes Spectrum 2008; 21: 19-25.
  23. Santoro D, Lucisano S, Gagliostro G, Alibrandi A, Benvenga S, et al. Vitamin D receptor polymorphism in chronic kidney disease patients with complicated cardiovascular disease. J Ren Nutr. 2015; 25: 187-193. Ref.: https://goo.gl/JDdtPo
  24. Fernandez Fernández E, Fibla J, Betriu A, Piulats JM, Almirall J, et al. Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure. J Am Soc Nephrol. 1997; 8: 1546-1552. Ref.: https://goo.gl/LGJ3XU
  25. Vigo GE, Cadarso-Suarez C, Perez-Fernandez R, Romero BR, Devesa MJ, et al. Association between vitamin D receptor FokI Polymorphism and serum parathyroid hormone level in patients with chronic renal failure. J Endocrinol Invest. 2005; 28: 117-121. Ref.: https://goo.gl/nSpKAD
  26. Yildiz A, Tepe S, Olfaz H, Yazici H, Ark E, et al. Carotid atherosclerosis is a predictor of coronary calcification in chronic hemodialysis patients. Nephrol Dial Transplant. 2004; 19: 885-891. Ref.: https://goo.gl/cQV5ic
  27. Ruiz MR, Cajavilca C, Varon J. Einthoven's string galvanometer the first electrocardiograph. Tex Heart Inst J. 2008; 35: 174-178. Ref.: https://goo.gl/QpEFcC
  28. Burtis CA, Ashwood ER, Bruns DE. Tietz Text Book of Clinical Chemistry and Molecular Diagnostics. 4th Ed. Elsevier Saunders Company, St Louis. 2006; 1689-1699.
  29. Gunes S, Sumer AP, Keles GC, Kara N, Koprulu H, et al. Analysis of vitamin D receptor gene polymorphisms in patients with chronic periodontitis. Indian J Med Res. 2008; 127: 58-64. Ref.: https://goo.gl/RUuhpf
  30. Mansour L, Sedky M, AbdelKhader M, Sabry R, Kamal M, et al. The role of vitamin D receptor genes (FOKI and BSMI) polymorphism in osteoporosis. Middle East Fertil Soc J. 2010; 15: 79-83.
  31. Daly LE, Bourke GJ. Interpretation and uses of medical statistics. 5th Ed. Blackwell Science, Oxford, Malden. 2000.
  32. Puri BK. SPSS in practice: an illustrated guide. 2nd Ed. Arnold, London, New York. 2002.
  33. Andress DL. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 2006; 65: 33-43. Ref.: https://goo.gl/qJpaVV
  34. Kumar P, Clark M. Kumar and Clark's Clinical Medicine. 7th Ed. Elsevier Saunders Company, Edinburgh, 2009; 628.
  35. Ozdemir FN, Sezer S, Atac B, Tutal E, Verdi H, et al. Vitamin D receptor BsmI and TagI gene polymorphisms in a Turkish ESRD population: influences on parathyroid hormone response. Transplant Proc. 2005; 37: 2922-2924. Ref.: https://goo.gl/JPJepx
  36. El Gawad SS, Samea ER, Sherif M, Elrakhawy MM. Vitamin D receptor genotypes, bone mineral density and biochemical markers of bone turnover in Egyptian premenopausal women with graves ' disease. New York Science Journal. 2012; 5: 54-61.
  37. Mostowska A, Lianeri M, Wudarski W, Olesińska M, Jagodziński PP. Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep. 2013; 40: 803-810. Ref.: https://goo.gl/EQBP9w
  38. Paul J, Dasgupta S, Ghosh MK. Carotid artery intima media thickness as a surrogate marker of atherosclerosis in patient with chronic renal failure on hemodialysis. N Am J Med Sci. 2012; 4: 77-80. Ref.: https://goo.gl/xBx8HS
  39. Rahman M, Smith MC. Hypertension in hemodialysis patients. Curr Hypertens Rep. 2001; 3: 496-502. Ref.: https://goo.gl/4FHxRf
  40. Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, et al. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003; 115: 291-297. Ref.: https://goo.gl/BoHgR3
  41. Agarwal R. Hypertension and survival in chronic hemodialysis patients-past lessons and future opportunities. Kidney Int. 2005; 67: 1-13. Ref.: https://goo.gl/ZoNdVG
  42. Stidley CA, Hunt WC, Tentori F, Schmidt D, Rohrscheib M, et al. Changing relationship of blood pressure with mortality over time among hemodialysis patients. J Am Soc Nephrol 2006; 17: 513-20. Ref.: https://goo.gl/ADveVN
  43. Pan XM, Li DR, Yang L, Wang EY, Chen TY, et al. No association between vitamin D receptor polymorphisms and coronary artery disease in a Chinese population. DNA Cell Biol 2009; 28: 521-525. Ref.: https://goo.gl/AE6sKT
  44. Ortlepp JR, Von Korff A, Hanrath P, Zerres K, Hoffmann R. Vitamin D receptor gene polymorphism BsmI is not associated with the prevalence and severity of CAD in a large-scale angiographic cohort of 3441 patients. Eur J Clin Invest. 2003; 33: 106-109. Ref.: https://goo.gl/EdWStv
  45. Yokoyama K, Nakashima A, Urashima M, Suga H, Mimura T, et al. Interactions between serum vitamin D levels and vitamin D receptor gene FokI polymorphisms for renal function in patients with type 2 Diabetes. PLoS One. 2012; 7: 16. Ref.: https://goo.gl/DHrnqj
  46. Baravkar PN, Bavikar JS, Asegaonkar SB, Bavikar SS, Bardapurkar JS, et al. Study of serum uric acid and C-reactive protein levels in patients with chronic renal disease. Int J Biol Med Res. 2013; 4: 2758-2761.
  47. Horl WH. The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes. Nephrol Dial Transplant. 2004; 19: 2-8. Ref.: https://goo.gl/k7FkdF
  48. Tagliabue J, Farina M, Imbasciati E, Vergani C, Annoni G. BsmI polymorphism of the vitamin D receptor gene in hyperparathyroid or hypoparathyroid dialysis patients. Am J Clin Pathol. 1999; 112: 366-370. Ref.: https://goo.gl/q9eGr3
  49. Nagaba Y, Heishi M, Tazawa H, Tsukamoto Y, Kobayashi Y. Vitamin D receptor gene polymorphisms affect secondary hyperparathyroidism in hemodialyzed patients. Am J Kidney Dis 1998; 32: 464-469. Ref.: https://goo.gl/eLjFSy
  50. Carling T, Kindmark A, Hellman P, Lundgren E, Ljunghall S, et al. Vitamin-D-receptor genotypes in primary hyperparathyroidism. Nat Med 1995; 1: 1309-1311. Ref.: https://goo.gl/C83PL2
  51. Tsukamoto Y, Heishi M, Nagaba Y, Kobayashi N, Nomura Y, et al. More on hyperparathyroidism and the vitamin D receptor. Nat Med. 1996; 2: 1162. Ref.: https://goo.gl/MXmztE
  52. Valdivielso JM, Fernandez E. Vitamin D receptor polymorphism and disease. Clin Chim Acta. 2006; 371: 1-12. Ref.: https://goo.gl/6nh7yN
  53. Giannini S, D'Angelo A, Nobile M, Carraro G, Rigotti P, et al. The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation. J Bone Miner Res. 2002; 17: 1768-1773. Ref.: https://goo.gl/vjM6Lz
  54. Falkiewicz K, Bidzinska B, Demissie M, Boratyńska M, Zmonarski SC, et al. Influence of vitamin D receptor gene polymorphisms on secondary hyperparathyroidism and bone density after kidney transplantation. Transplant Proc. 2005; 37: 1023-1025. Ref.: https://goo.gl/TXpce2
  55. Uitterlinden AG, Fang Y, van Meurs JB, Pols HA, van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338: 143-1456. Ref.: https://goo.gl/wYBjkt

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?